[ibogaine] C.R.A.C.K

preston peet ptpeet at nyc.rr.com
Sun Jul 21 15:10:49 EDT 2002


thanks howard
  ----- Original Message ----- 
  From: HSLotsof at aol.com 
  To: ibogaine at mindvox.com 
  Sent: Sunday, July 21, 2002 2:02 PM
  Subject: Re: [ibogaine] C.R.A.C.K



  In a message dated 7/21/02 1:38:23 PM, ptpeet at nyc.rr.com writes:

  >Hey Howard,
  >Is this up online somewhere, with a link, so I can link to it at Drugwar.com?
  >Thanks.
  >peace,
  >Preston

  Preston,

  The letter originated with http://www.advocatesforpregnantwomen.org/  but, I 
  didn't see it on their web page.  I just felt that Barbara Harris and 
  C.R.A.C.K were getting into dangerous areas.

  Howard
  *********
   ----- Original Message ----- 

    From: HSLotsof at aol.com 

    To: ibogaine at mindvox.com 

    Sent: Saturday, July 20, 2002 10:54 PM

    Subject: [ibogaine] C.R.A.C.K



    Barbara Harris 

    Children Requiring A Caring Kommunity's 

    "Project Prevention" 

    P.O. Box 74 

    Stanton, CA 90680 


    Dear Ms. Harris: 


    We are writing to express our strong objections to your distribution of 

    highly misleading and completely inaccurate information regarding pregnant 

    women and methadone treatment. In a letter date February 22, 2002, you 
  state, 

    in part: 


    "We are currently working with several methadone clinics that make our 
  offer 

    known, and available, to the women and men who come through their program. 

    I'm sure one thing most can agree on is that it is important for those 
  using 

    methadone or other drugs to refrain from getting pregnant." 


    We most certainly do not agree. Your statement, suggesting that it is 

    dangerous for a woman who is receiving clinically prescribed methadone 

    treatment to become pregnant, is simply wrong. Methadone is a highly 

    effective treatment for all opiate dependent patients and, most 
  specifically, 

    for women - both before and after they may become pregnant. In fact, 
  methadone

     treatment during pregnancy has not been associated with congenital 

    abnormalities or fetal demise. In those cases where neonatal withdrawal 

    symptoms occur (and they frequently do not), these symptoms can be treated 

    readily, with no evidence of any adverse impact on physical or cognitive 

    development. In short, there is simply no medical basis for your suggestion 

    that methadone patients should "refrain from getting pregnant." 


    For over 30 years, in countries throughout the world, methadone maintenance 

    treatment (MMT) has been shown to substantially reduce illegal opiate use 
  and 

    the crime, illness, suffering, and death with which it is associated. The 

    benefits have been shown to accrue, not only to the individual patient, but 

    to his/her family and the community, as well. The most credible and 
  objective 

    governmental and non-governmental organizations in America and abroad have 

    recognized these positive results with MMT. For example, the US Department 
  of 

    Health and Human Services joins the scientific community in recognizing 
  that 

    MMT greatly benefits the patients as well as the general community. It is 

    specifically recommended for pregnant and breast-feeding patients, which 

    further demonstrates the strong medical consensus supporting methadone 

    treatment, both in general and during pregnancy. 


    Unfortunately, despite methadone treatment's many benefits, it is available 

    to fewer than 20% of the people who most need it. Women, in particular, 
  face 

    numerous barriers to obtaining this important medical intervention. Your 

    letter and activities, which spread false information and stigmatize 
  current 

    and future mothers who receive this treatment, will make it even more 

    difficult for women who need methadone treatment to receive it. 


    We therefore urge you to withdraw this letter immediately and to advise 
  each 

    of those individuals and clinics who received it that it was based on 

    misinformation. Furthermore, it is essential that you publicly repudiate 
  the 

    inaccurate message you conveyed on your organization's website and in other 

    public and media context. Not to do so would be irresponsible and a great 

    disservice to those whose interests you claim to have at heart. 


    Signed, 



    Signatories 


    1. Lynn Singer, Ph.D, Professor of Pediatrics and Psychiatry, Case Western 

    Reserve University, School of Medicine 

    2. Stephen Kandall, MD, Retired Professor of Pediatrics, Albert Einstein 

    College of Medicine 

    3. Daniel Neuspiel, MD, MPH, Associate Chairman of Pediatrics, Beth Israel 

    Medical Center 

    4. Robert Newman, MD, Director, Baron Edmond de Rothschild Chemical 

    Dependency Institute of Beth Israel Medical Center 

    5. Barry Lester, Ph.D., Director, Infant Development Center, Women and 

    Infants’ Hospital 

    6. Mary Faith Marshall, Ph.D., Professor of Medicine and Bioethics, Kansas 

    University Medical Center 

    7. Maryann Amodeo, Ph.D., Professor, Boston University School of Social 
  Work, 

    Alcohol and Drug Institute for Policy, Research and Training 

    8. Denise Paone, Ph.D., Evaluation and Training Consultant, Former 
  Assistant 

    Director of Research, Chemical Dependency Institute, Beth Israel Medical 

    Center 

    9. John J. Botti, MD, Director, Maternal Fetal Medicine, Penn State Hershey 

    Medical Center 

    10. Mary Mahowald, Ph.D., Professor, Dept. of OB/GYN, University of Chicago 

    11. Machelle Allen, MD, Assistant Professor, Department of OB/GYN, NYU 
  School 

    of Medicine 

    12. Wendy Chavkin, MD, MPH, Clinical Professor of Public Health and OB/GYN, 

    Columbia University, Mailman School of Public Health 

    13. Marjorie Greenfield MD, Associate Professor of OB/GYN, University 

    Hospitals of Cleveland, Case Western Reserve University School of Medicine 

    14. Hytham Imseis, MD, Mountain Area Health Education Center, Dept. of 
  OB/GYN 

    15. Dona Upson, MD, Associate Professor of Medicine, University of New 
  Mexico 

    16. Mack Lipkin, Jr., MD, Director of Primary Care, NYU School of Medicine 

    17. Ernest Drucker, Ph.D., Professor of Epidemiology and Social Medicine, 

    Montefiore Medical Center/Albert Einstein School of Medicine 

    18. Angela R. Holder, LLM, Professor of the Practice of Medical Ethics, 

    Center for the Study of Medical Ethics and Humanities, Duke University 

    Medical Center 

    19. Sydney L. Hans, Ph.D., Research Associate Professor, Department of 

    Psychiatry, University of Chicago 

    20. Craig Reinarman, Ph.D., Chair and Professor, Dept. of Sociology, UC 
  Santa 

    Cruz 

    21. Rachel Roth, Ph.D., Assistant Professor, Washington University 

    22. Monica J. Casper, Ph.D., Associate Professor of Sociology, UC Santa 
  Cruz 

    23. Anthony R. Kovner, Ph.D., Professor of Health Policy and Management, 

    Wagner/NYU 

    24. Susan L. Adams, Ph.D., RN, Associate Professor of Nursing, 
  Women’s 

    Health Nurse Practitioner, Perinatal Addiction, Dominican University of 

    California 

    25. Nina Peskoe Peyser, Former Executive Director of the Chemical 
  Dependency 

    Institute at Beth Israel Medical Center 

    26. Holly Catania, Baron Edmond de Rothschild Chemical Dependency Institute 

    of Beth Israel Medical Center 

    27. Nancy D. Campbell, Ph.D., Assistant Professor, Rensselaer Polytechnic 

    Institute 

    28. Jerome Richardson, Assistant Professor, University of Illinois at 
  Chicago 

    29. Karyn L. Pomerantz, MLS, MPH, GW School of Public Health & Health 

    Services 

    30. Janet Lynne Golden, Ph.D., Associate Professor, Rutgers University 

    31. Cynthia Daniels, Ph.D., Associate Professor, Rutgers University 

    32. Drew Humphries, Ph.D., Department of Sociology, Anthropology and 
  Criminal 

    Justice, 

    Rutgers University 

    33. Elizabeth M. Armstong, Ph.D., Assistant Professor, Princeton University 

    34. Jael Silliman, Ed.D., Associate Professor, University of Iowa 

    35. Jeanne Flavin, Ph.D., Associate Professor, Fordham University 

    36. Victor J. Bernstein, Ph.D., Associate Professor, University of Chicago 

    37. Grace Chang, Ph.D., Evergreen State College 

    38. Mario A. Caro, Ph.D. Candidate, Professor, Evergreen State College 

    39. Phillip Coffin, MIA, Project Director, Center for Urban Epidemiologic 

    Studies, New York Academy of Medicine 

    40. Sheigla Murphy, Ph.D., Institute for Scientific Analysis 

    41. Leslie D. McCrory, Clinical Supervisor, Health Partners 

    42. Ann D. Brown, CNM, MSN, Dept. of OB/GYN, Mountain Area Health Education 

    Center 

    43. Shelley Galvin, MA, Research & Grants Coordinator, Dept. of OB/GYN, 

    Mountain Area Health Education Center 

    44. Susan Shinn, RNC, Women’s Health, Mountain Area Health Education 

    Center 

    45. Melissa McClure, Medical Records Coordinator, Mountain Area Perinatal 

    Substance Abuse Program 

    46. Cheryl Timbs, Clinical Supervisor, Mountain Area Perinatal Substance 

    Abuse Program 

    47. Elizabeth Finger, LWW, Director of Behavior Medicine, Mountain Area 

    Health Education Center 

    48. Terry Sutton, Program Assistant, Mountain Area Health Education Center 

    49. Jean Cassidy, Dept. of OB/GYN, Mountain Area Health Education Center 

    50. Steve Allison, Certified Clinical Addiction Specialist, Mountain Area 

    Health Education Center 

    51. Gregory McCoy, Mountain Area Perinatal Substance Abuse Program 

    52. Michael Eisenberg, MD, MPH, President, ASPIRE 

    53. Luciano Colonna, Executive Director, Harm Reduction Project 

    54. Michael R. Aldrich, Ph.D 

    55. Ivan Zimmerman, J.D. 

    56. Rickie Solinger, Ph.D., Historian 

    57. National Women's Health Network 

    58. National Black Women’s Health Project 

    59. National Association for Public Health Policy Council on Illicit Drugs 

    60. Institute for Health and Recovery 

    61. Advocates for Recovery through Medicine (ARM) 

    62. Advocates for Recovery through Medicine (ARM) of Arkansas & Oklahoma 

    63. Advocates for Recovery through Medicine (ARM) of DC 

    64. Connecticut Women’s Consortium 

    65. Casa Segura 

    66. Lower East Side Harm Reduction Center 

    67. Addiction Treatment Watchdog 

    68. CAP Quality Care Methadone Clinic 

    69. Virginia Alliance of Methadone Advocates 

    70. Vermont Harm Reduction Coalition 

    71. San Francisco AIDS Foundation HIV Prevention Project 

    72. AIDS Project New Haven 

    73. HIV Law Project 

    74. ASPIRE 

    75. Drug Policy Alliance 

    76. Urban Justice Center 

    77. Criminal Justice Policy Institute 

    78. Center for Human Rights Education 

    79. Family Watch 

    80. Committee on Women, Population, and the Environment 

    81. Cambridge Cares About AIDS 

    82. California Coalition for Women Prisoners 

    83. Legal Services for Prisoners With Children 

    84. NORML Foundation 

    85. Common Sense for Drug Policy 

    86. Drug Policy Forum of Hawaii 

    87. ReconsiDer 

    88. Communities Against Rape and Abuse 

    89. Mikki Norris, Human Rights and the Drug War 

    90. Alice Diorio, President, Vermont Harm Reduction Coalition 

    91. Kevin Zeese, Executive Director, Common Sense for Drug Policy 

    92. Donna M. Shea, Legal Director, NORML 

    93. Mark Beresky, Secretary/Treasurer, Vermont Harm Reduction Coalition 

    94. Marc Shinderman, MD, CAP Quality Care Methadone Clinic 

    95. Cassie Pierson, Staff Attorney, Legal Services for Prisoners with 

    Children 

    96. Monique Tula, Director of Harm Reduction Services, Cambridge Cares 
  About 

    AIDS 

    97. Eliza Wheeler, Needle Exchange Program Coordinator, Cambridge Cares 
  About 

    AIDS 

    98. Robin Clark-Smith, AIDS Program, Bridgeport Health Department 

    99. Terri Bogage, Institute for Health and Recovery 

    100. Syd Lindsley, Committee on Women, Population, and the Environment 

    101. Jacqueline Robarge, Power Inside 

    102. Stephanie Manfre, Children’s Case Manager, Riley Center 

    103. Ann Beck, Riley Center 

    104. Jennifer Grant, Director, Riley Center 

    105. Teresa Martyny, Riley Center 

    106. Kylie Chow, Brennan House 

    107. JoAnn Yang, Riley Center 

    108. Michelle Rivera, Riley Center 

    109. Carolina Alaniz, Riley Center 

    110. Idoia Irastorza, Riley Center 

    111. Megan Koroshetz, Riley Center 

    112. Stacy Benedict, Riley Center 

    113. Liliana Diaz, San Francisco Department of Public Health 

    114. Ellenie Tuazon, San Francisco Department of Public Health 

    115. Elba Warner, San Francisco Department of Public Health 

    116. Ebone Colbert, Communities Against Rape and Abuse 

    117. Theryn Kigvamasud’Vashti, Communities Against Rape and Abuse 

    118. Alisa Bierria, Program Coordinator, Communities Against Rape and Abuse 

    119. Shane Felles 

    120. Brion Roberts 

    121. Susan Yanow, Director, Abortion Access Project 

    122. Shiela VanDerveer, Development Director, NARAL – NH 

    123. NOW Legal Defense and Education Fund 

    124. Marsha Rosenbaum, Ph.D., Director, Safety First Project, Drug Policy 

    Alliance 

    125. Ann M. Boyer, MD, MS, Mt. Sinai Medical Center 

    126. Nancy Mamis-King, Associate Executive Director, Neighborhood Youth & 

    Family Services 

    127. Maureen Denman, Atlantic Health System 

    128. Shelly Carter, Health Educator, New Mexico Prenatal Care Network, 

    University of New Mexico 

    129. National Council on Alcoholism & Drug Dependence 

    130. Gloria Knighton 

    131. Virginia Nurses Society on Addictions 

    132. National Alliance of Methadone Advocates 

    133. National Advocates for Pregnant Women

   

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://www.mindvox.com/pipermail/ibogaine/attachments/20020721/0ac40697/attachment.html>


More information about the Ibogaine mailing list